Astal Laboratories Limited (BOM:512600)
58.67
-0.44 (-0.74%)
At close: Nov 20, 2026
Astal Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 292.29 | 147.09 | 89.25 | 7.85 | 0.16 | -0.17 |
Depreciation & Amortization | 26.99 | 11.97 | 2.23 | 0.3 | 0.08 | 0.15 |
Other Amortization | 0.31 | 0.31 | - | - | - | - |
Change in Accounts Payable | 141.16 | 453.45 | -7.4 | 77.22 | 37.93 | -0.62 |
Change in Other Net Operating Assets | -346.34 | -627.72 | -105.5 | -133.27 | -50.81 | 0.26 |
Other Operating Activities | -34.29 | -103.24 | 33.27 | 2.69 | -1.73 | -2.11 |
Operating Cash Flow | -218.98 | -176.99 | -125.17 | -55.79 | -14.37 | -2.49 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -20.98 | -13.93 | -57.75 | -59.17 | - | - |
Sale of Property, Plant & Equipment | 8.49 | - | - | - | - | 0.25 |
Cash Acquisitions | -2.96 | -2.96 | - | - | - | - |
Investment in Securities | -7.5 | -7.73 | -20.65 | - | - | - |
Net Decrease (Increase) in Loans Originated / Sold - Investing | 1.95 | - | - | -2.05 | 13.24 | - |
Other Investing Activities | 4.99 | 2.92 | 0.25 | 0.14 | 1.79 | 2.11 |
Investing Cash Flow | -16.03 | -21.7 | -78.14 | -61.08 | 15.03 | 2.36 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | 3.17 | 3.3 | - | - |
Long-Term Debt Repaid | - | -16.57 | -0.55 | -0.17 | - | - |
Lease Payments | -3.04 | -2.23 | - | - | - | - |
Net Debt Issued (Repaid) | -9.1 | -16.57 | 2.62 | 3.12 | - | - |
Issuance of Common Stock | - | - | - | 173.78 | - | - |
Other Financing Activities | 38 | 42.37 | 30.29 | -0.11 | - | - |
Financing Cash Flow | 19.5 | 25.8 | 32.91 | 176.8 | - | - |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -215.5 | -172.89 | -170.41 | 59.92 | 0.66 | -0.13 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -239.96 | -190.91 | -182.92 | -114.96 | -14.37 | -2.49 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6.11% | -7.68% | -28.70% | -48.61% | -39.83% | -118.03% |
Free Cash Flow Per Share | -7.04 | -10.14 | -16.48 | -22.76 | -3.62 | -0.63 |
Free Cash Flow After Leases | -243 | -193.15 | -182.92 | -114.96 | -14.37 | -2.49 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 13.33 | 19.43 | 7.01 | 0.11 | - | - |
Cash Income Tax Paid | 7.2 | 10.21 | 3.01 | 0.3 | 0.1 | 0 |